We hereby inform you that the Company has fixed Tuesday, 24th March, 2026 as record date in order to determine the number of shareholders entitled for bonus equity shares in the ratio of 1:1
BONUS
▲ Positive Development
LOW RISK
📅 Filed on BSE: 17 Mar 2026, 03:20 PM IST · BSE ID: 68741172-90c6-4cc0-ba9a-a62f2468f04d
View Original BSE Filing (PDF)
💡
In Simple Terms
The company will double shareholder holdings by issuing one free bonus share for every share currently owned, effective 24 March 2026.
🤖 AI Summary
- Kilitch Drugs fixes record date 24 March 2026 for bonus shares in 1:1 ratio
- One bonus equity share of Rs. 10/- for every one equity share held by shareholders
- Deemed allotment date: Wednesday, 25 March 2026 per SEBI circular 16 September 2024
- Eligible shareholders: all holding physical or electronic shares as of record date closing
🔢 Key Numbers — exact figures from BSE filing, not rounded
Bonus Ratio
1:1 (one bonus equity share of Rs. 10/- for every one equity share of Rs. 10/-)
Record Date
Tuesday, 24 March 2026
Deemed Allotment Date
Wednesday, 25 March 2026
🏢 How This Affects the Company
Share capital will double upon bonus allotment. Paid-up capital will increase proportionally with the 1:1 bonus issuance, diluting per-share earnings metrics.
👥 What This Means For Shareholders
✅
Action Required
No action required. All shareholders holding shares on record date 24 March 2026 automatically receive bonus shares.
👤
Who Is Affected
All shareholders with shares registered in physical form or in electronic form via depositories as of closing hours on 24 March 2026 are entitled to bonus. Share count for each shareholder doubles without additional investment.
🔍
Management Signal
Board approval of bonus indicates confidence in equity base and intent to enhance shareholder base liquidity and accessibility.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Confirmation of allotment on or after 25 March 2026 — verify bonus shares credited to demat accounts
Updated shareholding pattern post-bonus — check if promoter and institutional holding percentages adjust
Next earnings announcement — monitor EPS impact from doubled share count on same profits
LOW RISK
Bonus is routine corporate action with minimal execution risk. Record date and process clearly defined. No financial or operational downside identified.
💡 Investor Takeaway
Kilitch Drugs will issue bonus equity shares in 1:1 ratio on record date 24 March 2026. Shareholders holding shares as of closing on that date receive one free share per share held. Allotment deemed effective 25 March 2026.
⚖️ Strengths & Concerns
✅ Positives
- Bonus issuance signals shareholder wealth distribution and confidence in equity base strength.
- Shareholder participation is automatic — no action required from existing shareholders to benefit.
⚠️ Concerns
- Share count doubles, reducing earnings per share (EPS) proportionally if net profit remains unchanged.
- No details provided on impact on promoter holding percentage or control structure post-bonus.
📅 Company Track Record
Kilitch Drugs is a pharmaceutical manufacturing company incorporated in 1992 (CIN: L24239MH1992PLCO66718). Listed on BSE (524500) and NSE (KILITCH). Operating since 1992 from manufacturing facility in Navi Mumbai. This bonus issuance reflects standard capital management practice in Indian pharma sector.
Based on publicly available historical data. For context only.